Dear Editors,
We read with interest the article by Cakir et al. [1] who describe a child who had febrile episodes of ascites, without any extraabdominal complaints at disease onset.
The patient did not fulfill the diagnostic criteria for familial Mediterranean fever (FMF; MIM no.#249100) [2] , and genetic testing did not reveal any known mutation in the MEFV gene. Nevertheless, the resolution of symptoms determined by colchicine within few days since its administration and the absence of disease flares at 12-month follow-up, both strengthened the presumptive diagnosis of FMF. The later onset of skin eruptions constituted a probable FMF diagnosis. Peritoneal effusion during abdominal attacks is commonly observed in FMF and is often related to serosal peritoneal inflammation. The effusion is usually mild and is not detectable by clinical evaluation, disappearing during symptom-free intervals [3] . Only rarely it may develop into ascites with large amounts of peritoneal fluid [4] , and it is also uncommon that patients present ascites as the inaugural sign of FMF. To date, Cakir et al. have described the first pediatric patient with this unusual presentation. Since an increasing interest is currently being devoted to serosal involvement in autoinflammatory disorders [5] , we would like to present some additional data on our personal experience with adult-onset autoinflammatory disorders and their presentation with isolated serosal involvement occurring with fever. Among monogenic periodic fever syndromes, the inflammatory involvement of the serosal membranes is reported both for FMF, caused by mutations in the MEFV gene, and for tumor necrosis factor receptor-associated periodic syndrome (TRAPS), caused by mutations in the TNFRSF1A gene [6] . Both disorders are characterized by recurrent episodes of fever associated with abdominal and chest pain, arthralgia and/or arthritis, and cutaneous manifestations. FMF and TRAPS typically manifest in the pediatric population, with onset ranging from the first months to the first decade of life, while a limited number of patients experience disease onset during adulthood. Lateonset FMF is fairly rare, with 14-30% of patients with FMF manifesting the disease in late adulthood [3, 7] up to the age of 65, as we recently reported [8] . Adult-onset FMF seems to be related to low-penetrance mutations and, although patients may experience milder disease, the clinical manifestations are usually similar to those of younger patients, except that arthritis and erysipela-like erythema occur at significantly lower frequencies in adults [7] . Disease onset in adulthood has been described for TRAPS as well, up to the age of 63 [9] and, as with FMF, is frequently related to low-penetrance mutations [9, 10] . Patients with adult-onset TRAPS may be characterized by a phenotype that can mimic FMF in the duration of inflammatory attacks, which may last less than 1 week [11] . In addition, patients with adult-onset TRAPS may present atypical clinical manifestations, such as recurrent serosal involvement of pericardium as the sole clinical manifestation [9, 12, 13] . Among these subjects, we recently hypothesized the criteria for identifying patients for whom testing for genetic mutations of the TNFRSF1A gene should be carried out [12, 13] . Atypical presentations of FMF have also been increasingly reported in the literature and, as with TRAPS, often manifest with isolated serosal involvement (pericardium, peritoneum and pleura) [1, 14, 15] .
Recently, a diagnostic score for improving genetic diagnosis of recurrent periodic fever in children under the age of 10 has been proposed with the aim of increasing the probability of obtaining positive results [16] . In addition, with the aim of improving genetic diagnosis in adults suspected with autoinflammatory disorders, we have recently identified some variables that appear to be strongly related to the probability of detecting gene mutations in MEFV and TNFRSF1A, and we have also developed a diagnostic score for identifying patients at high risk to carry these mutations (unpublished data, manuscript submitted). Both scores might represent two evidence-based guidelines, thus helping in the diagnostic evaluation of patients (pediatric and adult), including those presenting with atypical and incomplete disease, thus helping clinicians to identify those who may be carriers of mutations in ''autoinflammatory genes''.
Since all patients enrolled in both studies were of Italian origin, the multivariate analysis could not evaluate the ethnic origin among the possible discriminating variables. Nevertheless, the ethnic origin should obviously be taken into consideration when patients from populations with a high prevalence of mutations of a certain gene are examined [17] .
Cakir et al., as we did with recurrent pericarditis [13, 14] , suggested that clinicians should keep FMF in mind in the differential diagnosis of massive ascites especially in regions where hereditary inflammatory diseases are common.
Nevertheless, further evaluations are needed in order to establish criteria that can identify the few patients among those with isolated recurrent serositis that could be carriers of mutations in the genes of autoinflammatory diseases.
